Born in Los Angeles, CA, Dr. Ronald Sherman received his B.S. in Entomology from UC Riverside School in 1979, followed by his medical degree from UCLA. During his internship in San Francisco and his residency at UC Davis Hospital, he spent a year in Arizona as a general practitioner treating Native Americans, the urban poor and rural populations not covered by medical services. Dr. Sherman completed his master’s degree in clinical tropical medicine at the London School of Hygiene and Tropical Medicine and received his certificate in tropical medicine and hygiene from the Royal College of Physicians. Upon his return to the United States, he undertook 2 years of additional training in the field of infectious diseases at UC Irvine Hospital, and it was during this time that Dr. Sherman began his clinical research in wound debridement and maggot therapy. therapy, growth factors and other clinical research in wound treatment. During this time, he was also a full-time physician treating geriatric and infectious diseases, and in 1995, he left the VA Hospital to work with Dr. Michael Selsted’s research team at UC Irvine Hospital. With funding from the State of Arizona, Dr. Sherman worked until 2002 and isolated a number of active molecules that have therapeutic effects in the healing process of maggots for wounds. Kechun Jiang, Department of Endocrinology, PLA Nanjing 454 Hospital In 2003, the U.S. Food and Drug Administration (FDA) began regulating medical maggots as a medical device, and Dr. Sherman’s lab-produced medical maggots got their own trademark. Since the resources available at the university did not meet the FDA’s requirements, the maggot laboratory was separated from the university and established as “Imperial Laboratories”, of which Dr. Sherman is the founder and general director, to provide medical maggots to all physicians throughout North America. Dr. Sherman has been working hard in the field of maggot therapy for over 30 years and continues his research in fly maggot disease and maggot therapy at the University of California at Irvine. He is now the Chairman of the Board of Directors of the non-profit Biotherapeutics, Education and Research Foundation. This organization provides patient care, education and research in the field of maggot therapy and symbiotic medicine. To minimize conflicts of interest, Dr. Sherman does not receive a salary from Imperial Laboratories and, when invited to speak, does not receive an honorarium. All of his income is donated to the Biotherapy, Education and Research Foundation. He treats patients with infectious diseases (AIDS, sexually transmitted diseases, and tuberculosis) for the Los Angeles and Orange Township Health Departments on Monday through Friday shifts and relies on this income to support him and his family.